Hydrocephalus Market Expected to Achieve 6% CAGR by 2029: Growth Forecast Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Hydrocephalus Market Size By 2025?
The market for hydrocephalus has seen consistent expansion in the last few years. The market size is anticipated to rise from $3.54 billion in 2024 to $3.69 billion in 2025, with a compound annual growth rate (CAGR) of 4.3%. The historical period's growth is primarily associated with increased understanding of neurological disorders, advancements in pediatric healthcare, a rising incidence of traumatic brain injuries, enhanced healthcare accessibility, and efforts in research and development.

How Big Is the Hydrocephalus Market Size Expected to Grow by 2029?
Anticipated strong expansion is on the horizon for the hydrocephalus market. It is predicted to augment to a value of $4.66 billion in 2029, growing at a compound annual growth rate (CAGR) of 6.0%. Factors propelling growth during this forecast period include breakthroughs in neuroendoscopy, a rising elderly population, regulatory backing for medical appliances, an upswing in traumatic brain injuries, and global health endeavors. Key trends to watch for within this period are greater emphasis on child neurology, novel developments in shunt systems, strides forward in medical tech, improvements in surgical practices, and innovations in shunt technologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/hydrocephalus-global-market-report

Which Key Market Drivers Powering Hydrocephalus Market Expansion and Growth?
The rise in the number of hydrocephalus cases contributes significantly to the expansion of the hydrocephalus market. Hydrocephalus manifests as a medical condition where there is an accumulation of cerebrospinal fluid (CSF) in the brain's cavities, leading to different cognitive abnormalities. The escalating instances of hydrocephalus are fueling the need for specialized treatment devices for this disorder. For example, the Hydrocephalus Association, a private non-profit organization based in the U.S., confirmed in August 2022 that hydrocephalus has impacted roughly 1 million US citizens, with a diagnosis rate of 1 in every 770 infants. Furthermore, about 700,000 elderly individuals in the U.S are suffering from normal pressure hydrocephalus (NPH). Hence, the surging prevalence of hydrocephalus is anticipated to accelerate the growth of the hydrocephalus market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6259&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Hydrocephalus Market?
Leading companies in the hydrocephalus market are pioneering new advanced products like endovascularly implantable cerebrospinal fluid (CSF) shunts. These are designed to enhance the treatment of hydrocephalus by offering a less invasive method to regulate CSF flow and alleviate intracranial pressure. An endovascularly implantable CSF shunt is a specific type of shunt system that is introduced into the blood vessels (endovascularly) to control hydrocephalus, which manifests as an abnormal accumulation of CSF in the brain. For example, in August 2024, CereVasc Inc., a clinical-stage medical device company based in the USA, gained approval from the Food and Drug Administration (FDA), an American federal agency responsible for public health protection, for its eShunt System. This medical device is engineered to treat Normal Pressure Hydrocephalus (NPH). The system features an endovascularly implantable CSF shunt intended to obviate the requirement for invasive surgery and general anesthesia. The implantation procedure for the eShunt will be carried out using local anesthesia via a minimally invasive femoral venous approach in an angiography suite, a dedicated medical facility.

What Are the Emerging Segments in the Hydrocephalus Market?
The hydrocephalus market covered in this report is segmented -

1) By Type: Congenital Hydrocephalus, Acquired Hydrocephalus, Normal-Pressure Hydrocephalus, Ex-Vacuo Hydrocephalus
2) By Age Group: Pediatric, Adult
3) By Diagnostics: MRI, CT Scan, Head Ultrasound, Other Diagnostics
4) By End User: Hospitals, Diagnostic Centers, Academic Institutions, Research Organizations

Subsegments:
1) By Congenital Hydrocephalus: Associated With Genetic Disorders, Associated With Neural Tube Defects
2) By Acquired Hydrocephalus: Post-Traumatic Hydrocephalus, Hydrocephalus Due To Tumors, Hydrocephalus Following Infection
3) By Normal-Pressure Hydrocephalus (NPH): Idiopathic Normal-Pressure Hydrocephalus, Secondary Normal-Pressure Hydrocephalus
4) By Ex-Vacuo Hydrocephalus: Hydrocephalus Related To Brain Atrophy, Hydrocephalus Following Stroke Or Injury

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=6259&type=smp

Who Are the Global Leaders in the Hydrocephalus Market?
Major companies operating in the hydrocephalus market include Johnson & Johnson Corporation, Thermo Fisher Scientific, Medtronic plc, MIZUHO Co. Ltd., B. Braun Melsungen AG, Helios Hospital, Agilent Technologies Inc., Texas Children's Hospital, Boston Children's Hospital, Karl Storz Se And Co. Kg, Integra LifeSciences Corporation, Children's National Hospital, Natus Medical Incorporated, Aesculap Inc., HLL Lifecare Limited, Sophysa SA, Anadolu Medical Center, Christoph Miethke GmbH & Co. KG, Alcyone Therapeutics Inc., Moller Medical GmbH, Spiegelberg GmbH & Co. KG, G. SURGIWEAR LTD., Tokibo Co. Ltd., HpBio Proteses Inc., Desu Medical, Dispomedica GmbH, Kaneka Medix Corporation, Delta Surgical Limited

Which are the Top Profitable Regional Markets for the Hydrocephalus Industry?
North America was the largest region in the hydrocephalus market in 2024. The regions covered in the hydrocephalus market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6259

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.